The Patent Finder

Shanghai Yingli Pharmaceutical Co., Ltd.

9 patents currently held · Updated Nov 21, 2026
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Previously recorded as Shanghai Yingli Science and Technology Co., Ltd. (to 2015)

0
Ending by 2030
Sep 2034
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

No maintenance fee falls due on this company's record before Nov 21, 2027.

Recent changes

  • 1 of the patents on this record was granted since Aug 23, 2026
  • 2 terms have ended since Aug 23, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 9 of 9

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,745,321Fused pyrimidine compound, intermediate, preparation method therefor, and composition and application thereof
In force
 · USPTO record
In forceUSPTO record
US 9,656,996Fused heterocyclic compound, preparation method therefor, pharmaceutical composition, and uses thereof
In force
 · USPTO record
In forceUSPTO record
US 10,100,015Condensed ring derivative, and preparation method, intermediate, pharmaceutical composition and use thereof
In force
 · USPTO record
In forceUSPTO record
US 11,466,003Nitrogenous Heterocyclic Aromatic Compound, Preparation Method Therefor, Pharmaceutical Composition Thereof, and Application Thereof
In force
 · High confidence
In forceHigh confidence
US 11,168,072Crystal Form of Morpholino Quinazoline Compound, Preparation Method Therefor and Use Thereof
In force
 · High confidence
In forceHigh confidence
US 11,584,745Aromatic Heterocyclic Compound, Intermediate Thereof, Preparation Method Therefor, and Pharmaceutical Composition and Use Thereof
In force
 · High confidence
In forceHigh confidence
US 11,505,542Preparation method for morpholinquinazoline compound and intermediates thereof
In force
 · USPTO record
In forceUSPTO record
US 12,799,132Crystal Form of URAT1 Inhibitor Puliginurad and Preperation Thereof
In force
 · High confidence
In forceHigh confidence
US 12,655,140Compound containing structure of a heteroaromatic ring, pharmaceutical composition thereof and application thereof
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 9: 1 patent in force now held by others · 4 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 pending · 2 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited